January 16, 2026
Thank you for all your efforts on this study so far!
Sites can expect Protocol Amendment 4.0 standard materials (Pocket Protocols, Inclusion/Exclusion cards, and Visit Schedules) onsite in the coming week.
Please login and sign off on your site specific ICF, if not already completed.
Participant retention is critical for study success, regardless of treatment assignment. Should you have any concerns with participant retention due to adverse events or schedule of assessment based for those participants no longer on IP, please reach out to the Medpace Medical team with your CRA in copy.
Autoinjector distribution details will be available soon! As a forthcoming update in PAV5.0 will add scheduling flexibility with the transition to autoinjectors. Stay tuned for communication on these updates and the final protocol.

.png)